Second Nature (Clinics/Outpatient Services) logo

Second Nature (Clinics/Outpatient Services)

Website
Current Valuation
$46.5M
As of May 26, 2024
Total Funding Raised
$29.0M
Last Round
Later Stage VC

$540.0K

Last Funding
May 2024

Funding date

Capital Efficiency
1.61x

Valuation / Funding

Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones

No funding history available

Funding data has not been imported for this company yet

Valuation Analysis

Current Valuation Metrics

Second Nature (Clinics/Outpatient Services) is currently valued at $46.5M as of May 26, 2024. The company has raised a total of $29.0M in funding.

Capital Efficiency

With a capital efficiency ratio of 1.61x, Second Nature (Clinics/Outpatient Services) has achieved a valuation that is 1.61 times the total capital raised. This metric indicates room for improvement in capital deployment.

Investment Perspective

Second Nature (Clinics/Outpatient Services)'s valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.

Track Second Nature (Clinics/Outpatient Services) Valuation Updates

Get notified when Second Nature (Clinics/Outpatient Services) raises new funding or valuation changes

Explore More Data
Detailed analysis for Second Nature (Clinics/Outpatient Services)

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

What is Second Nature (Clinics/Outpatient Services) Worth in 2025?

As of 2025, Second Nature (Clinics/Outpatient Services) is valued at $46.5M, based on the company's Later Stage VC funding round in May 26, 2024. This valuation positions Second Nature (Clinics/Outpatient Services) as one of the leading private companies in the sector.

Second Nature (Clinics/Outpatient Services) Valuation History

Second Nature (Clinics/Outpatient Services)'s funding history demonstrates steady growth and investor confidence.

How Second Nature (Clinics/Outpatient Services) Valuation is Determined

Private company valuations like Second Nature (Clinics/Outpatient Services)'s are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:

  • Revenue growth and financial performance
  • Market opportunity and total addressable market (TAM)
  • Competitive positioning and market share
  • Management team strength and execution capability
  • Technology and intellectual property
  • Industry trends and investor sentiment

Second Nature (Clinics/Outpatient Services) Valuation FAQs

Is Second Nature (Clinics/Outpatient Services) profitable?

Second Nature (Clinics/Outpatient Services) has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.

How does Second Nature (Clinics/Outpatient Services)'s valuation compare to competitors?

Second Nature (Clinics/Outpatient Services) is valued at $46.5M, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.

When will Second Nature (Clinics/Outpatient Services) IPO?

Second Nature (Clinics/Outpatient Services) has not announced plans for an initial public offering. Until an IPO, investors can access Second Nature (Clinics/Outpatient Services) shares through secondary market platforms.